NewAmsterdam Pharma Company N.V.

NAMSW ·Healthcare, Drug Manufacturers - General, Netherlands
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $478.5M

Liabilities Breakdown FY2022

Total Liabilities: $48.4M